Status:
COMPLETED
Vasti Control of Patellofemoral Kinematics in Asymptomatic Volunteer
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
Abnormalities
Patellofemoral Pain Syndrome
Eligibility:
All Genders
18-55 years
Brief Summary
Background: * Patellofemoral pain syndrome is one of the most common knee problems. It is characterized by pain in the front of the knee that is aggravated by deep knee flexion, prolonged sitting, an...
Detailed Description
Patellofemoral pain syndrome is one of the most common problems of the knee. It is characterized by anterior knee pain that is aggravated by deep knee flexion, prolonged sitting, and repetitive flexio...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Healthy male and female volunteers between the ages of 18 and 55.
- \<TAB\>
- EXCLUSION CRITERIA:
- Any relevant medical problems (connective tissue problems, active arthritis, etc.)
- Any clinical signs of a knee impairment in the joint being studied, including abnormal range of motion, muscle weakness, malaligment, and ligament damage.
- Any serious injury to the joint being studied, previous surgery on the joint being studied or extreme pain at the joint being studied.
- Allergy/hypersensitivity to lidocaine.
- Liver disease.
- Open angle glaucoma.
- Cardiac arrhythmias, congenital heart disease.
- G6PD.
- Any female who is pregnant.
- A volunteer will be excluded if they have a contraindication to MR imaging. Examples include:
- Metal within their body, which might be expected to concentrate radiofrequency fields or cause tissue damage from twisting in a magnetic field (e.g., aneurysm clip, implanted neural stimulator, implanted cardiac pacemaker or autodefibrillator, cochlear implant, ccular foreign body (e.g. metal shavings, insulin pump).
- A condition, which would preclude them from participating in an MR imaging study (e.g., paralyzed hemidiaphragm, morbid obesity, severe claustrophobia).
- A condition that presents an unnecessary risk to them or their unborn child (e.g., pregnancy, previous surgery of uncertain type, symptoms of pheochromocytoma or insulinoma).
Exclusion
Key Trial Info
Start Date :
October 22 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00978003
Start Date
October 22 2009
Last Update
December 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892